Deconstructing Moderna’s COVID-19 Patent Pledge
In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.
compulsory licensing
-
Read more: Deconstructing Moderna’s COVID-19 Patent Pledge -
Read more: COVID-19 Vaccine Advance Purchases Explained COVID-19 Vaccine Advance Purchases Explained
No vaccine for the novel coronavirus has been approved. Nevertheless, governments and organizations are making deals for tens of millions of doses.
-
Read more: Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS Webinar, 6/28: Procedural Aspects of Compulsory Licensing under TRIPS
Join us at yet another webinar with J. Wested at the University of Copenhagen. This time we will debate procedural issues in compulsory licensing with H. Grosse Ruse-Kahn (University of Cambridge) & M. Desai (Eli Lilly). Further information on our webinar series is available at here, here, and below: Procedural Aspects of Compulsory Licensing under Trade-Related Aspects of Intellectual…